Retaglutide is a novel GLP-1 receptor agonist currently under study for the treatment of metabolic disorders. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://ihannaviva349679.jts-blog.com/37728284/trelaglutide-exploring-a-new-option-for-chronic-diseases